A4IFN2
Gene name |
MEDAG |
Protein name |
Mesenteric estrogen-dependent adipogenesis protein |
Names |
|
Species |
Bos taurus (Bovine) |
KEGG Pathway |
bta:510187 |
EC number |
|
Protein Class |
|
Descriptions
The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.
Autoinhibitory domains (AIDs)
Target domain |
|
Relief mechanism |
|
Assay |
cis-regPred |
Accessory elements
No accessory elements
Autoinhibited structure
Activated structure
1 structures for A4IFN2
| Entry ID | Method | Resolution | Chain | Position | Source |
|---|---|---|---|---|---|
| AF-A4IFN2-F1 | Predicted | AlphaFoldDB |
15 variants for A4IFN2
| Variant ID(s) | Position | Change | Description | Diseaes Association | Provenance |
|---|---|---|---|---|---|
| rs462702999 | 3 | G>W | No | EVA | |
| rs480488453 | 26 | W>G | No | EVA | |
| rs461799777 | 41 | L>R | No | EVA | |
| rs523419766 | 52 | G>A | No | EVA | |
| rs383646846 | 56 | V>L | No | EVA | |
| rs136609127 | 83 | Q>R | No | EVA | |
| rs137586654 | 128 | L>S | No | EVA | |
| rs451792097 | 155 | V>I | No | EVA | |
| rs469445625 | 156 | I>S | No | EVA | |
| rs433414525 | 156 | I>V | No | EVA | |
| rs478029592 | 185 | V>G | No | EVA | |
| rs462770018 | 195 | E>V | No | EVA | |
| rs447498633 | 234 | T>S | No | EVA | |
| rs135544431 | 247 | I>V | No | EVA | |
| rs381540982 | 259 | V>I | No | EVA |
No associated diseases with A4IFN2
No regional properties for A4IFN2
| Type | Name | Position | InterPro Accession |
|---|---|---|---|
| No domain, repeats, and functional sites for A4IFN2 | |||
1 GO annotations of cellular component
| Name | Definition |
|---|---|
| cytoplasm | The contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures. |
No GO annotations of molecular function
| Name | Definition |
|---|---|
| No GO annotations for molecular function |
1 GO annotations of biological process
| Name | Definition |
|---|---|
| positive regulation of fat cell differentiation | Any process that activates or increases the frequency, rate or extent of adipocyte differentiation. |
| 10 | 20 | 30 | 40 | 50 | 60 |
| MAGLESAPAA | RPSLTSISSG | ELRSLWTCDC | ELALLPLGQL | LRLQPGAFQL | RGDQLVVPAP |
| 70 | 80 | 90 | 100 | 110 | 120 |
| AEPASARGGF | NVFGDGFVRL | DGQLYRLSSY | MRRYVELTNY | CDYKDYRETI | LSKPMLFFVH |
| 130 | 140 | 150 | 160 | 170 | 180 |
| VQTKKDSLKE | RTYAFLVNTR | HPKIRRQIEQ | GMDMVISSVI | GESYRLQFDF | QEVVKNFFPP |
| 190 | 200 | 210 | 220 | 230 | 240 |
| GNKVVNGEDL | SFAYEFKADA | LFDFFYWFGL | SNSTVKVNGK | VLNLSSTSPE | KKETIKLFLE |
| 250 | 260 | 270 | 280 | 290 | 300 |
| KMSEPLIRRS | SFSDRKFSVT | SRGSIDEVFN | CNLSPRSSLM | EPLVAELPFP | CVLESEETPN |
| PFI |